Suberoylanilide hydroxamic acid (SAHA)- Induced dynamics of a human histone deacetylase protein interaction network

Molecular and Cellular Proteomics

Volumn 13, Issue 11, 2014, Pages 3114-3125

  Sardiu, Mihaela E ^a   Smith, Karen T ^a   Groppe, Brad D ^a   Gilmore, Joshua M ^a   Saraf, Anita ^a   Egidy, Rhonda ^a   Peak, Allison ^a   Seidel, Chris W ^a   Florens, Laurence ^a   Workman, Jerry L ^a   Washburn, Michael P ^a,b  

^a STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRMS1 PROTEIN; BRMS1L PROTEIN; HISTONE DEACETYLASE; ING2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VORINOSTAT; CELL RECEPTOR; HISTONE DEACETYLASE INHIBITOR; HOMEODOMAIN PROTEIN; HYDROXAMIC ACID; ING2 PROTEIN, HUMAN; PROTEIN BINDING; TUMOR SUPPRESSOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; UPREGULATION; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR CELL LINE;

CELL LINE, TUMOR; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HOMEODOMAIN PROTEINS; HUMANS; HYDROXAMIC ACIDS; PROTEIN BINDING; PROTEIN INTERACTION MAPS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIN3 HISTONE DEACETYLASE AND COREPRESSOR COMPLEX; TRIPLE NEGATIVE BREAST NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84910601317     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.037127     Document Type: Article

References (46)

1. Brouwers, L., Iskar, M., Zeller, G., van Noort, V., and Bork, P. (2011) Network neighbors of drug targets contribute to drug side-effect similarity. PLoS One 6, e22187
2. Paolini, G. V., Shapland, R. H., van Hoorn, W. P., Mason, J. S., and Hopkins, A. L. (2006) Global mapping of pharmacological space. Nat. Biotechnol. 24, 805-815
3. Rix, U., and Superti-Furga, G. (2009) Target profiling of small molecules by chemical proteomics. Nat. Chem. Biol. 5, 616-624
4. Ververis, K., Hiong, A., Karagiannis, T. C., and Licciardi, P. V. (2013) Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents. Biologics 7, 47-60
5. Hashioka, S., Klegeris, A., and McGeer, P. L. (2012) The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-gamma. J. Neuroinflamm. 9, 113
6. Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A., Steffan, J. S., Marsh, J. L., Thompson, L. M., Lewis, C. M., Marks, P. A., and Bates, G. P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 100, 2041-2046
7. Chuang, D. M., Leng, Y., Marinova, Z., Kim, H. J., and Chiu, C. T. (2009) Multiple roles of HDAC inhibition in neurodegenerative conditions. Trends Neurosci. 32, 591-601
8. New, M., Olzscha, H., and La Thangue, N. B. (2012) HDAC inhibitor-based therapies: can we interpret the code? Mol. Oncol. 6, 637-656
9. Munoz, I. M., MacArtney, T., Sanchez-Pulido, L., Ponting, C. P., Rocha, S., and Rouse, J. (2012) Family with sequence similarity 60A (FAM60A) protein is a cell cycle-fluctuating regulator of the SIN3-HDAC1 histone deacetylase complex. J. Biol. Chem. 287, 32346-32353
10. Ludwig, S., Klitzsch, A., and Baniahmad, A. (2011) The ING tumor suppressors in cellular senescence and chromatin. Cell Biosci. 1, 25
11. Ayer, D. E., Lawrence, Q. A., and Eisenman, R. N. (1995) Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767-776
12. Sommer, A., Hilfenhaus, S., Menkel, A., Kremmer, E., Seiser, C., Loidl, P., and Luscher, B. (1997) Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol. 7, 357-365
13. Wotton, D., Knoepfler, P. S., Laherty, C. D., Eisenman, R. N., and Massague, J. (2001) The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Diff. 12, 457-463
14. Smith, K. T., Sardiu, M. E., Martin-Brown, S. A., Seidel, C., Mushegian, A., Egidy, R., Florens, L., Washburn, M. P., and Workman, J. L. (2012) Human family with sequence similarity 60 member A (FAM60A) protein: a new subunit of the Sin3 deacetylase complex. Mol. Cell. Proteomics 11, 1815-1828
15. Smith, K. T., Martin-Brown, S. A., Florens, L., Washburn, M. P., and Workman, J. L. (2010) Deacetylase inhibitors dissociate the histonetargeting ING2 subunit from the Sin3 complex. Chem. Biol. 17, 65-74
16. Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., and Pavletich, N. P. (1999) Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. Nature 401, 188-193
17. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A. M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., Boesche, M., Delling, M., Dumpelfeld, B., Eberhard, D., Huthmacher, C., Mathieson, T., Poeckel, D., Reader, V., Strunk, K., Sweetman, G., Kruse, U., Neubauer, G., Ramsden, N. G., and Drewes, G. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes. Nat. Biotechnol. 29, 255-265
18. Joshi, P., Greco, T. M., Guise, A. J., Luo, Y., Yu, F., Nesvizhskii, A. I., and Cristea, I. M. (2013) The functional interactome landscape of the human histone deacetylase family. Mol. Syst. Biol. 9, 672
19. Unoki, M., Kumamoto, K., and Harris, C. C. (2009) ING proteins as potential anticancer drug targets. Curr. Drug Targets 10, 442-454
20. Dignam, J. D., Martin, P. L., Shastry, B. S., and Roeder, R. G. (1983) Eukaryotic gene transcription with purified components. In: Methods in Enzymology (Wu, R., Grossman, L., and Moldave, K., eds), pp. 582-598, Academic Press, New York
21. Swanson, S. K., Florens, L., and Washburn, M. P. (2009) Generation and analysis of multidimensional protein identification technology datasets. Methods Mol. Biol. 492, 1-20
22. McDonald, W. H., Ohi, R., Miyamoto, D. T., Mitchison, T. J., and Yates, J. R., 3rd (2002) Comparison of three directly coupled HPLC MS/MS strategies for identification of proteins from complex mixtures: singledimension LC-MS/MS, 2-phase MudPIT, and 3-phase MudPIT. Int. J. Mass Spectrom. 219, 245-251
23. Eng, J. K., McCormack, A. L., and Yates, J. R., 3rd (1994) An approach to correlate tandem mass spectral data of peptides with amino acid se-quences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989
24. Tabb, D. L., McDonald, W. H., and Yates, J. R., 3rd (2002) DTASelect and Contrast: tools for assembling and comparing protein identifications from shotgun proteomics. J. Proteome Res. 1, 21-26
25. Zhang, Y., Wen, Z., Washburn, M. P., and Florens, L. (2010) Refinements to label free proteome quantitation: how to deal with peptides shared by multiple proteins. Anal. Chem. 82, 2272-2281
26. Choi, H., Fermin, D., and Nesvizhskii, A. I. (2008) Significance analysis of spectral count data in label-free shotgun proteomics. Mol. Cell. Proteomics 7, 2373-2385
27. Pavelka, N., Fournier, M. L., Swanson, S. K., Pelizzola, M., Ricciardi-Castagnoli, P., Florens, L., and Washburn, M. P. (2008) Statistical similarities between transcriptomics and quantitative shotgun proteomics data. Mol. Cell. Proteomics 7, 631-644
28. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis, K. J., Scherf, U., and Speed, T. P. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4, 249-264
29. Smyth, G. K. (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Applicat. Genet. Mol. Biol. 3, Article3
30. Shi, X., and Garry, D. J. (2012) Sin3 interacts with Foxk1 and regulates myogenic progenitors. Mol. Cell. Biochem. 366, 251-258
31. McDonel, P., Demmers, J., Tan, D. W., Watt, F., and Hendrich, B. D. (2012) Sin3a is essential for the genome integrity and viability of pluripotent cells. Dev. Biol. 363, 62-73
32. Mosley, A. L., Sardiu, M. E., Pattenden, S. G., Workman, J. L., Florens, L., and Washburn, M. P. (2011) Highly reproducible label free quantitative proteomic analysis of RNA polymerase complexes. Mol. Cell. Proteomics 10, M110.000687
33. Le Guezennec, X., Vermeulen, M., Brinkman, A. B., Hoeijmakers, W. A., Cohen, A., Lasonder, E., and Stunnenberg, H. G. (2006) MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol. Cell. Biol. 26, 843-851
34. Sardiu, M. E., Gilmore, J. M., Carrozza, M. J., Li, B., Workman, J. L., Florens, L., and Washburn, M. P. (2009) Determining protein complex connectivity using a probabilistic deletion network derived from quantitative proteomics. PLoS One 4, e7310
35. Simboeck, E., Sawicka, A., Zupkovitz, G., Senese, S., Winter, S., Dequiedt, F., Ogris, E., Di Croce, L., Chiocca, S., and Seiser, C. (2010) A phosphorylation switch regulates the transcriptional activation of cell cycle regulator p21 by histone deacetylase inhibitors. J. Biol. Chem. 285, 41062-41073
36. Zupkovitz, G., Grausenburger, R., Brunmeir, R., Senese, S., Tischler, J., Jurkin, J., Rembold, M., Meunier, D., Egger, G., Lagger, S., Chiocca, S., Propst, F., Weitzer, G., and Seiser, C. (2010) The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation. Mol. Cell. Biol. 30, 1171-1181
37. Sekhavat, A., Sun, J. M., and Davie, J. R. (2007) Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Biochem. Cell Biol. 85, 751-758
38. Miller, C. P., Singh, M. M., Rivera-Del Valle, N., Manton, C. A., and Chandra, J. (2011) Therapeutic strategies to enhance the anticancer efficacy of histone deacetylase inhibitors. J. Biomed. Biotechnol. 2011, 514261
39. Librizzi, M., Longo, A., Chiarelli, R., Amin, J., Spencer, J., and Luparello, C. (2012) Cytotoxic effects of Jay Amin hydroxamic acid (JAHA), a ferrocene-based class I histone deacetylase inhibitor, on triple-negative MDA-MB231 breast cancer cells. Chem. Res. Toxicology 25, 2608-2616
40. Tate, C. R., Rhodes, L. V., Segar, H. C., Driver, J. L., Pounder, F. N., Burow, M. E., and Collins-Burow, B. M. (2012) Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat. Breast Cancer Res. 14, R79
41. Shi, X., Hong, T., Walter, K. L., Ewalt, M., Michishita, E., Hung, T., Carney, D., Pena, P., Lan, F., Kaadige, M. R., Lacoste, N., Cayrou, C., Davrazou, F., Saha, A., Cairns, B. R., Ayer, D. E., Kutateladze, T. G., Shi, Y., Cote, J., Chua, K. F., and Gozani, O. (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442, 96-99
42. Ruefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K. M., Kofler, R., Smyth, M. J., and Johnstone, R. W. (2001) The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 98, 10833-10838
43. Wozniak, M. B., Villuendas, R., Bischoff, J. R., Aparicio, C. B., Martinez Leal, J. F., de La Cueva, P., Rodriguez, M. E., Herreros, B., Martin-Perez, D., Longo, M. I., Herrera, M., Piris, M. A., and Ortiz-Romero, P. L. (2010) Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma. Haematologica 95, 613-621
44. Brazelle, W., Kreahling, J. M., Gemmer, J., Ma, Y., Cress, W. D., Haura, E., and Altiok, S. (2010) Histone deacetylase inhibitors downregulate checkpoint kinase 1 expression to induce cell death in non-small cell lung cancer cells. PLoS One 5, e14335
45. Magnaghi-Jaulin, L., Eot-Houllier, G., Fulcrand, G., and Jaulin, C. (2007) Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint. Cancer Res. 67, 6360-6367
46. Zhang, Y., De, S., Garner, J. R., Smith, K., Wang, S. A., and Becker, K. G. (2010) Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information. BMC Med. Genomics 3, 1